SSanlioglu VMD, PhD

Gene and Cell Therapy of Genetic Diseases | Ne Mutlu Türküm Diyene |

[SSanlioglu VMD, PhD @ssanlioglu]

Greetings everyone! We are exited to share that our latest review article, CAR-T Cell Gene Therapy https://t.co/nFa7eYZbAT

[SSanlioglu VMD, PhD @ssanlioglu]

I am pleased to share our newly published review on base editing https://t.co/CWBgSSx06C

[SSanlioglu VMD, PhD @ssanlioglu]

Enjoy reading our recent article on SARS-CoV-2 https://t.co/oV6iFmQNtJ

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/RpGSzvnXfF

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/hpWTMDnEjL

[SSanlioglu VMD, PhD @ssanlioglu]

Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease, explores a transformative alternative: a single-dose, precision-based gene therapy capable of achieving long-lasting cholesterol reduction.
https://t.co/B5QGvGVftr

[SSanlioglu VMD, PhD @ssanlioglu]

My dear colleagues,
We are delighted to share our newest article on genome editing and hope you find the content valuable. We encourage you to review the findings and consider their potential impact on the future of medical genetics. https://t.co/8uexAK6ivG

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/H65nJ5siIw

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/F4chBsyjyR

[SSanlioglu VMD, PhD @ssanlioglu]

Hey everyone,
We’ve put together an article on gene editing that we think you and your team will really enjoy. Hope you have a great time reading it!

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/3tPBkcDpVn

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/wXZb9abjov

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/QB2KxzPYYJ

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/gb07uLIAKk

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/L9CyxhuwUb

[liugroup @liugroup]

This year's Precision Medicine World Conference (@PMWCintl) is right around the corner!

For those who can join, @davidrliu's presentation will be part of the "Cell & Gene Therapies" Track on 02/06.

Full program lineup: https://t.co/Umj70tEdvz

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/25zeZDSnQJ

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/zRflS2tJBp

[SSanlioglu VMD, PhD @ssanlioglu]

https://t.co/SuGPakUo7C

[SSanlioglu VMD, PhD @ssanlioglu]

The European Commission gave conditional approval to Hemgenix, an infusion gene therapy for adults with hemophilia B and no inhibitors. https://t.co/LDZogdHkJt